TRAUMA
Osteogenic protein-1 is safe and effective in the treatment of tibial nonunion
This report has been verified
by one or more authors of the
original publication.
J Bone Joint Surg Am. 2001;83-A Suppl 1(Pt 2):S151-8
122 patients with 124 tibial nonunions were treated with intramedullary nailing and randomized to receive a fresh bone autograft or recombinant human osteogenic protein-1 (rhOP-1). Patients were assessed for severity of pain at the fracture site, the ability to walk with full weightbearing, need for surgical re-treatment of the nonunion, radiographic evaluation of healing, and physician satisfaction with the clinical course. Clinical and radiographic judgments of healing were not significantly different between the two groups through 2 years.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
